HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $468,408 | +8.6% | 12,262 | +2.6% | 0.00% | 0.0% |
| Q2 2023 | $431,181 | +11.1% | 11,954 | +17.7% | 0.00% | 0.0% |
| Q1 2023 | $387,972 | -47.1% | 10,159 | -21.2% | 0.00% | -50.0% |
| Q4 2022 | $733,157 | +32.1% | 12,885 | -8.2% | 0.00% | +33.3% |
| Q3 2022 | $555,000 | -10.2% | 14,035 | -0.1% | 0.00% | 0.0% |
| Q2 2022 | $618,000 | +10.0% | 14,044 | -0.3% | 0.00% | +50.0% |
| Q1 2022 | $562,000 | +18.6% | 14,092 | +19.5% | 0.00% | 0.0% |
| Q4 2021 | $474,000 | +3.5% | 11,793 | +4.7% | 0.00% | 0.0% |
| Q3 2021 | $458,000 | -6.9% | 11,259 | +3.8% | 0.00% | 0.0% |
| Q2 2021 | $492,000 | +13.4% | 10,842 | +4.1% | 0.00% | 0.0% |
| Q1 2021 | $434,000 | +3.1% | 10,412 | +5.7% | 0.00% | 0.0% |
| Q4 2020 | $421,000 | +188.4% | 9,854 | +77.4% | 0.00% | +100.0% |
| Q3 2020 | $146,000 | +3550.0% | 5,556 | +4015.6% | 0.00% | – |
| Q2 2020 | $4,000 | +100.0% | 135 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | 0.0% | 135 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | -94.3% | 135 | -93.2% | 0.00% | – |
| Q3 2017 | $35,000 | +34.6% | 2,000 | 0.0% | 0.00% | – |
| Q2 2017 | $26,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2017 | $26,000 | +1200.0% | 2,000 | +900.0% | 0.00% | – |
| Q3 2016 | $2,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |